# Efficacy and Safety Assessment for a New UV-protected Pump Infusion Line in Intravenous Infusion Therapy

> **NCT04309708** · NA · COMPLETED · sponsor: **B. Braun Medical International Trading Company Ltd.** · enrollment: 300 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DEVICE:** Nimodipine pump infusion

## Key facts

- **NCT ID:** NCT04309708
- **Lead sponsor:** B. Braun Medical International Trading Company Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-09-06
- **Final completion:** 2019-09-08
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309708, "Efficacy and Safety Assessment for a New UV-protected Pump Infusion Line in Intravenous Infusion Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04309708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*